MAP3K1 and cancer: Second, we did not investigate the association between genetic variations in MAP3K1 rs889312 and patients’ responses to anti-cancer drugs, primarily because different chemotherapies were employed in our patients which results in a lack of statistical power to detect responses to drug effects.